SightfileU.S. market data from official filings

Companies › CERS

CERUS CORP (CERS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001020214 · EDGAR filings · Updated 2026-07-20

CERUS CORP (CERS) has reported institutional ownership of 75.7%, with 167 institutional managers holding positions valued at $275.9M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01).

Institutional ownership
75.7%
Institutional managers
167
Reported 13F value
$275.9M
Insider activity
36 trans.
−$2.61M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CERUS CORP has 167 institutional holders and institutional ownership of 75.7%.

Insider activity

Insiders reported 36 transactions (1 buys, 17 sells) across 13 reporting insiders, with a net reported value of −$2.61M.

Data flags from SEC filings

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2021-01-29 (recurring since 2021-01-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

AQUESTIVE THERAPEUTICS INC (AQST) · INVIVYD INC (IVVD) · FULGENT GENETICS INC (FLGT) · CORMEDIX INC (CRMD) · STANDARD BIOTOOLS INC (LAB) · SAB BIOTHERAPEUTICS INC (SABS)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.